Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Status:
Recruiting
Trial end date:
2023-10-15
Target enrollment:
Participant gender:
Summary
The overarching objective of this study is to determine the clinical effectiveness of
dupilumab for the treatment of CRS that includes several potential disease endotypes with the
exclusion of the nasal polyp cluster that has previously been determined. The additional
information gained from secondary and exploratory outcomes will help provide important
insight for applied research studies and may also provide practical guidance to clinicians on
how to select patients for treatment.